We welcome abstract submissions from researchers, clinicians, and scientists working across all areas of radiopharmaceutical sciences.

Details on abstract categories, formatting requirements, and the submission portal will be available when submissions open on September 2, 2026.

Questions?

Contact Elaine Murray, Associate Executive Director emurray@srsweb.org

(Also found in the submission system)

The body of the abstract is limited to 500 words; this includes any words used in tables as part of the abstract body.
Abstract title and author/affiliation information do not count against the 500 word total.
Only one .JPG image may be uploaded, though you may combine up to three images into one .JPG file. Images will be displayed electronically in color.
Organize your abstract according to the standard subtitles: Objectives, Methods, Results, Conclusions, and Acknowledgments/References. If you want to view an abstract example, download Guidelines and Example Abstracts for Authors.
You are also strongly encouraged to follow the nomenclature guidelines (DOI: 10.1016/j.nucmedbio.2017.09.004) recently published by an international working group.
Use only one table in the body of your abstract or, possibly, two small tables.
Your abstracts must include actual data and not simply be an overview.
If the abstract refers to a compound, the compound should be properly identified (not simply a number).
The structure of novel compounds should be discussed in the acceptable abstract.
You will be able to add co-authors to the Abstract once you click “Submit.” When adding co-authors who are already in the database system, you cannot modify their affiliation or any of their profile data - the co-author must modify their own data. They can do this by visiting the profile home.